HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ocular myasthenia gravis in a senior population: diagnosis, therapy, and prognosis.

Abstract
The objectives of this study were (I) to explore the prognosis of ocular myasthenia gravis (OMG) in patients with onset at age 70 years and above (i.e. senior persons); (2) to identify predictors of secondary generalization in this age group; and 3) to address the effects of immunotherapy on this population of patients. We performed a retrospective analysis of 39 patients with myasthenia gravis who presented with only ocular signs and symptoms after age 70 years. Generalized myasthenia gravis (GMG) developed in 12 OMG patients (31%). None of the GMG patients required ventilator assistance or a feeding tube. Of the 12 ocular patients progressing to GMG, only one (8%) received immunotherapy prior to generalization. Of those OMG patients who did not progress to GMG, 52% received immunomodulatory therapy. Our senior OMG patients had a prognosis comparable with those of the published data for younger individuals. Although the presence of increased acetylceholine receptor antibody titers and occasionally abnormal repetitive nerve stimulation were useful tools to diagnose OMG, no test was predictive of later generalization. Senior onset OMG patients who received immunotherapy less frequently developed GMG than those not so treated.
AuthorsJeffrey A Allen, Stephanie Scala, H Royden Jones
JournalMuscle & nerve (Muscle Nerve) Vol. 41 Issue 3 Pg. 379-84 (Mar 2010) ISSN: 1097-4598 [Electronic] United States
PMID19918767 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Cyclosporine
  • Azathioprine
  • Prednisone
Topics
  • Age Factors
  • Age of Onset
  • Aged
  • Aged, 80 and over
  • Azathioprine (therapeutic use)
  • Chi-Square Distribution
  • Cyclosporine (therapeutic use)
  • Disease Progression
  • Disease-Free Survival
  • Electric Stimulation
  • Electromyography
  • Female
  • Humans
  • Immunotherapy
  • Male
  • Myasthenia Gravis (diagnosis, immunology, therapy)
  • Patient Selection
  • Plasma Exchange
  • Prednisone (therapeutic use)
  • Prognosis
  • Remission Induction
  • Retrospective Studies
  • Severity of Illness Index
  • Thymectomy
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: